WOUND HEALING ACTIVITY OF JATROPHA TANJORENSIS LEAVES

Madepalli Byrappa gowdu Viswanathan1, Jesu Doss Jeya Ananthi2 *  NataRajan Livingston Raja2, Narayanan Venkateshan2

1Department of Plant Science, Bharathidasan University, Tiruchirappalli 620 024, Tamil Nadu, India

2Department of Pharmaceutics, Arulmigu Kalasalingam College of Pharmacy, Krishnankoil – 626126, Tamil Nadu, India

DOI: https://doi.org/10.22270/ujpr.v3i5.198

ABSTRACT

The term “wound” is defined as a disruption of normal anatomical structure. Therefore, “healing” is the complex and dynamic process that results in the restoration of anatomical continuity and function. Albino Wistar rats (150-180 g) of both sexes were selected. The experiment of Wound Healing Activity by Excision Wound Model and Incision Wound Model by the simple ointment B.P., reference standard drug (0.2% w/w nitrofurazone ointment), stigmasterol ointment (0.2% w/w), hexane, chloroform and methanol extract ointments of 3%, 4% and 5% w/w of leaves in Jatropha tanjorensis in simple ointment base (where 3g, 4g and 5 g of the extracts was incorporated in 100 g of simple ointment separately). The time for wound closure to methanol extract ointment (5% w/w) and stigmasterol (0.2% w/w) was similar to that of standard drug, nitrofurazone ointment (0.2% w/w) 16±2 days in Excision Wound Model. The significant tensile strength at 3%: 4%: 5% w/w methanol extract ointments (p<0.001), followed by chloroform extract and hexane extract. Stigmasterol ointment at 0.2% w/w produced tensile strength comparable with Standard drug, nitrofurazone ointment (0.2% w/w) (p<0.001) in Incision Wound Model. Juice of the Jatropha plant and the pounded leaves are applied to wounds and refractory ulcers. The juice is very successfully used to treat scabies, eczema and ringworm. The present study proved that the leaves have wound healing activity.

Keywords:   Excision, incision wound Jatropha tanjorensis, leaves, wound healing.

INTRODUCTION

The genus Jatropha belongs to tribe Joanneasiae of Crotonoideae in the Euphorbiaceae family and contains approximately 175 species, cultivated throughout the tropical to temperate regions of the world. The name is derived from the  Greek words ?ατρ?ς (iatros), meaning "physician," and τροφ?  (trophe), meaning "nutrition" as food. Homeopathically it is used for cold sweats, colic, collapse cramps, cyanosis, diarrhea, and leg cramps. The root, stem, leaves, fruit, seed, bark and latex of the plant are largely used for the treatment of many diseases in different parts of the world1.  The juice of the plant and the pounded leaves are applied to wounds and refractory ulcers. The juice is very successfully used to treat scabies, eczema and ringworm2.

Leaves are regarded as antiparasitic, applied to scabies, rubefacient for paralysis, rheumatism; also applied to hard tumors3.  According to Ochse4, “The young leaves may be safely eaten, steamed or stewed”. They are favored for cooking with goat meat, said to counteract the peculiar smell. It is reported to be abortifacient, anodyne, antiseptic, cicatrizant, depurative, diuretic, emetic, hemostatic, lactogogue, narcotic, purgative, rubefacient, styptic, vermifuge, and vulnerary5, 6. Latex is applied topically to bee and wasp stings7 and to dress sores and ulcers and inflamed tongues8. Duke and Wain6 list it for homicide, piscicide, and raticide as well. Colombians drink the leaf decoction for venereal disease9. The latex was strongly inhibitory to watermelon mosaic virus10Jatropha tanjorensis11 Shrubs, 3-4 m high; stem long, stout, dichotomously branched; branches puberulous when young, glabrous when mature.

Distribution

India: Tiruchirappalli, Pudukottai, Thanjavur and Ramanathapuram Districts in Tamil Nadu and Pondicherry. 

West Africa including Nigeria: Weed of field crops, bush re-growth, roadside and disturbed places in the higher rainfall zones.

The aim of the present study is to study the wound healing effects of leaves of Jatropha tanjorensis against Excision Wound and Incision Wound in rats. This plant has not been studied for their wound healing effect.

MATERIALS AND METHODS

Plant Material

Leaves of Jatropha tanjorensis were collected in the vicinity of Pondicherry.  An authentic herbarium specimen (MBV and JJ 14774) was prepared and deposited in the Herbarium of the Centre for Research and Development in Siddha-Ayurveda Medicines (CRDSAM), Department of Plant Science, Bharathidasan University, Tiruchirappalli 620 024, Tamil Nadu, India, for reference.

Preparation of plant extracts

The collected plants were dried at room temperature, pulverized by a mechanical grinder, sieved through 40 mesh. The powdered materials were extracted with hexane, chloroform and methanol using Soxhlet extraction apparatus. The chloroform and methanolic extract was then concentrated and dried under reduced pressure. The methanol free semi-solid mass thus obtained was used for the experiment12.

Pharmacology

Toxicity of both the extracts and isolated compounds (Friedelin, β–amyrin, stigmasterol and R-(+)4-hydroxy-2-pyrrolidinone) was fixed for biological evaluation following the Organization for Economic Cooperation and Development (OECD) guidelines (2001). LD50 values were calculated with no sign of acute toxicity at >2000 mg/kg for the extracts and 10 mg/kg for the isolated compounds. Animal studies were performed with the approval of the Institutional Animal Ethics Committee (IAEC) in Arulmigu Kalasalingam College of Pharmacy, Krishnan Koil 626126 (Reg. No. 509/01/C/CPCSEA - Committee for the Purpose of Control and Supervision on Experimental Animals, Department of Animal Welfare, Government of India (No. 412). Experimental animals housed under standard conditions were fed with standard diet (Lipton India Ltd., Bangalore) and water ad libitum in the Animal House, and maintained at room temperature under suitable nutritional and environmental conditions throughout the experiment. Fine chemicals were purchased from Sigma-Aldrich, St. Louis, MO 63103, and S.D. Fine Chemicals, Mumbai, India, and other chemicals from SISCO Research Laboratories Pvt. Ltd., Mumbai, India.

Wound Healing Activity

Excision Wound Model

Albino Wistar rats (150-180 g) of both sexes were selected to carry out the experiment. Twelve groups of 6 animals in each group were anaesthetized with ether.  The rats were depilated at the back and a predetermined area of 500 mm2 full thickness skin was excised at the dorsal interscapular region. Rat wounds were left undressed to the open environment. This model was used to monitor wound contraction and epithelization time. The simple ointment B.P., reference standard drug (0.2% w/w nitrofurazone ointment), stigmasterol ointment (0.2% w/w), hexane, chloroform and methanol extract ointments of 3%, 4% and 5% w/w in simple ointment base (where 3g, 4g and 5 g of the extracts was incorporated in 100 g of simple ointment separately) were applied everyday till the wound was completely healed. The progressive changes in wound area were monitored planimetrically by tracing the wound margin on a graph paper every alternate day. The changes in healing of wound, i.e., the measurement of wound area on graph paper were expressed as unit (mm2). Wound contraction was expressed as percentage reduction of original wound size13,14.

Incision Wound Model

Twelve groups of 6 animals in each group were taken and anaesthetized under light ether anesthesia. The incision wound13,14 with one full thickness paravertebral incision of 6 cm length was made including the cutaneous muscles of the depilated back of each rat. Full aseptic measures and no local or systemic antimicrobials were not used throughout the experiment. After incision, the parted skin was kept together and stitched with sutures, 1 cm apart. The continuous threads on both wound edges were tightened for good adaptation of wound and it was left undressed. The ointment of all the extracts 3%, 4% and 5% w/w, stigmasterol ointment (0.2% w/w), standard drug (nitrofurazone ointment) and simple ointment B.P. were applied to the wound  twice daily, until complete recovery to the respective groups of animals 15,16.

Measurement of Healing

On the 9th day after wounding, the sutures were removed and tensile strength was measured on 10th day. For measuring the tensile strength, the rats were again anesthetized and each rat was placed on a stack of towels at the middle of the board.  The amount of the towels could be adjusted in such a way so that the wound was at the same level as the tips of the arms. The clamps were then carefully clamped on the skin of the opposite edges of the wound. The longer pieces of the fishing line were placed on the pulley and finally to the polyethylene bottle. The position of board was adjusted to rate water from a large reservoir, until the wound began to open.  The amount of water in the polyethylene bottle was weighed and equated as the tensile strength of the wound. The tensile strength induced by the extracts, stigmasterol ointment (0.2% w/w), and the nitrofurazone ointment-treated wounds was compared with Control.

RESULTS

Excision Wound Model

Wound area (mm2) and the percentage of wound contraction produced by different extract ointments (3%: 4%: 5% w/w) were respectively such as 12±10.30; 97.69%: 10±8.40; 98.06%: 9±6.20; 98.07% (p<0.001) to methanol extract ointment and 8.9±5.6; 99.00% (p<0.001) to stigmasterol (0.2% w/w) on 16th day; and 10±0.40; 98.11%: 9±0.30; 98.29%: 7±0.20; 98.66% to hexane extract and 9±0.70; 98.30 %: 8±0.40%; 98.48%: 6±0.20; 98.85% to chloroform extract on 18th day. The time for wound closure to methanol extract ointment (5% w/w) and stigmasterol (0.2% w/w) was similar to that of standard drug, nitrofurazone ointment (0.2% w/w) 16±2 days (Table 1; Figure 1).

Incision Wound Model

The sutures were removed and measured tensile strength (in g±S.E.M.) at 3%: 4%: 5% w/w of different extract ointments was 578±10.20: 581±10.40: 584±10.90 (p<0.001) to methanol extract, 528±9.50: 532± 9.70: 535±10.10 to chloroform extract and  519±9.60: 521±9.80: 526±10.00 (p<0.001) to hexane extract. Stigmasterol ointment at 0.2% w/w produced tensile strength of 591±14.60 (p<0.001). Standard drug, nitrofurazone ointment (0.2% w/w) produced significant increase of tensile strength such as 597±14.80 (p<0.001) (Table 2; Figure 2).

DISCUSSION

The term “wound” is defined as a disruption of normal anatomical structure and more importantly function. Therefore, “healing” is the complex and dynamic process that results in the restoration of anatomical continuity and function17.  Acute wounds normally heal in a very orderly and efficient manner characterized by four distinct but overlapping phases such as hemostasis, inflammation, proliferation and remodeling18.  These steps are orchestrated in a controlled manner by a variety of bioactive molecules like growth factors, cytokines, their receptors and matrix molecules19. Such a controlled phenomenon can be disrupted in diseases like diabetes, immuno-compromised persons, ischemia, etc., thus leading to the development of a chronic wound.  Prolonged or incomplete wound healing is then a troublesome complication20.

Excision Wound Model

Nath and Dutta21 isolated the protease namely curcain from the latex of J. curcas and reported its effective wound healing property by excision wound model in mice. Ointments of 0.5% and 1.0% (w/w) curcain were compared with 0.2% (w/w) nitrofurazone ointment and 0.15% (w/w) propamidine isethionate cream. Curcain ointments healed the wound completely within 10 days of treatment whereas the nitrofurazone ointment and propamidine isethionate cream took 15 and 20 days respectively to show the same results. Esimone et al.22 tested ointments at 0.5 g/10 g, 1 g/10 g and 1.5 g/10 g of the methanol leaf extract in J. curcas, standard gentamycin and blank ointment on the excision wound in rats and their respective wound area on 21 day was 1.33±0.07, 0.2±0.03, 0.00±0.00, 0.00±0.00, and 3.90±0.28 and epithelization period was 17.80±0.84, 17.00±0.71, 14.80±0.45, 14.60±0.90 and 18.80±0.84. Methanol leaf extract ointments 1 g/10 g and 1.5 g/10 g and gentamycin showed significantly higher rate of wound healing (P<0.05) and reduced epitheliazation period. 

The results in the present study showed respective wound area and the percentage of wound contraction for the methanol leaf extract ointments at 3% w/w: 4% w/w: 5% w/w as 12±10.30; 97.69%: 10±8.40; 98.06%: and 8.9±5.6; 99.00% (p<0.001) on 16th day and 9±0.70; 98.30%: 8±0.40%; 98.48%: 6±0.20; 98.85% to chloroform extract and 10±0.40%; 98.11: 9±0.30; 98.29%: 7±0.20; 98.66% to hexane extract on 18th day.  Stigmasterol (0.2% w/w) produced 9±6.2; 98.07% (p<0.001) on 16th day.  The standard drug, nitrofurazone ointment (0.2% w/w) produced 0.00; 100% on 16th day. The time for wound closure to methanol extract ointment (5% w/w) and stigmasterol (0.2% w/w) was similar to that of nitrofurazone ointment (0.2% w/w) 16±2 days. The results suggested that topical application of the test drugs in animals significantly enhanced the rate of wound healing as assessed by wound area and the percentage of wound contraction. The time of wound closure for the ointments was observed such as 14±2 days to standard drug, 16±2 days to methanol extract and stigmasterol, 18±2 days to chloroform and hexane extract in a dose-dependent manner. Increasing the concentration of the extract is directly proportionate to the increase in wound contraction percentage (Table 1; Figure 1). Treated excision wounds showed an increased rate of wound contraction, leading to faster healing as confirmed by the increased wound healing area compared to control.

Incision wound model

Tensile strength for control was 432±13.30 g (Table 2; Figure 2). The increased tensile strength was 591±14.60 g, 584±10.90 g, 535±10.10 g and 526±10.00 g for stigmasterol, methanol, chloroform and hexane extracts (5% w/w) respectively. While the standard ointment-treated group showed 597±14.80 g.  At 4% and 3% w/w, the extracts showed decreased tensile strength such as 581±10.40 g and 578±10.20 g to methanol extract, 532±9.70 g and 528±9.50 g to chloroform extract and 521±9.80 g and 519±9.60 g to hexane extract. It is well-accepted that several local growth factors help in the wound healing process.  It is possible that the test extracts may have a growth factor-like activity or have the ability to stimulate the expression of growth factors like the basic fibroblast growth factor (bFGF).  The bFGF has the broadest range of target cells such as endothelial cells, fibroblasts, myoblasts, etc.23. Wound contraction is mediated by specialized myofibroblasts found in the granulated tissue24.  The increase in tensile strength of treated wounds may be due to increase in collagen concentration and stabilization of the fibers13,25.

Excision and Incision Wound Models

Shetty et al.26 recorded very effective property to accelerate wound healing process to the crude bark extract of J. curcas in Wistar albino rats.  Odoh et al.27 reported the wound healing property of methanol leaf extract in J. curcas by incision and excision wound models in rats. The wound healing effect at 200 mg/kg was compared to that of standard, cicatrin, and showed significant healing potential (P<0.05) in dose-dependent manner for the increase in wound contraction rate and skin breaking strength and decrease in epithelization period.

Further, secondary infections by microbes in the wounds may further aggravate the conditions. Some of the important organisms include Staphylococcus aureus, Streptococcus pyogenes, Corynebacterium species, Escherichia coli and Pseudomonas aeruginosa wherein the most common are Staphylococcus aureus and β-hemolytic Streptococcus species28 which are considered as “transient flora” of the skin29Pseudomonas aeruginosa is the predominant organism, which causes air-borne infection and its frequency of infection is more in burn patients. Infected wounds heal more slowly and have an increased incidence of scarring30.  Mycotic infections are also an important etiology of these infections, most of them are caused by dermatophytes and other related fungi.  A wide range of antibiotics are being used at present for healing wounds and for treating wound infections but they are now proved to have adverse effects in the human body.  In view of these developments, so much of attention has been paid recently to the extracts of biologically active compounds isolated from plant species used in herbal medicinal system31.

Pro-inflammatory cytokines were implicated to stimulate the synthesis of platelet activating factors by the recruited monocytes which in turn induce several angiogenic factors and chemokines32. Moon et al.33 reported the pronounced improvement of type-I collagen material invasion by β-sitosterol which acts as an angiogenic factor in wound healing. Angiogenesis is the growth of new vascular capillary channels from pre-existing vessels and is of fundamental importance in a number of physiological processes such as embryonic development, reproduction, wound healing and bone repair34. When wounding occurs it is accompanied within quite a short time by pain, reddening and edema of the surrounding tissue.  These are all classical symptoms of inflammation and are caused by the release of the eicosanoids, prostaglandins and leutkotrienes and of ROS.

The release of other factors such as the cytokines is also important which is caused by neutrophils aggregating at the wound site and producing proteolytic enzymes and ROS as antimicrobial defenses and as aids to the debridement of dead tissue. As the test extracts of J. tanjorensis exhibited potent anti-inflammatory and antioxidant activities these properties could have contributed to wound healing in part. Apart from the role of antioxidants in removing products of inflammation, they are also beneficial in wound healing in some other means.   Antioxidants counter the excess proteases and ROS often formed by neutrophils accumulation in the wound area and protect protease inhibitors from oxidative damage.  Fibroblasts and other cells may be killed by excess ROS and skin lipids will be made less flexible. So, antioxidant substances will reduce the possibility of occurrence of these adverse events.   Because of these factors, overall antioxidant effects appear to be important in the successful treatment of wounds35.  In the present study, the test extracts were shown to be strongly antioxidant due to the presence of flavonoids and polyphenols.

Open wounds are particularly prone to infection, especially by bacteria and superficial mycotic agents and also provide an entry point for systemic infections. Infected wounds heal less rapidly and also often result in the formation of unpleasant exudates and toxins that will be produced with concomitant killing of regenerating cells35. Staphylococcus aureus, Streptococcus pyogenes and Pseudomonas aeruginosa are the most common wound pathogens with≥103 CFU/g tissues which were classified as infection36.  The presence of saponins, flavonoids and other phenolics in the test extracts and their potent polyvalent activity due to their anti-inflammatory, antioxidant and antimicrobial properties could have contributed to the wound healing because of their detergent ability  to  remove  grease,  dirt  and  bacteria  from  tissue  and  act  as antimicrobials37,38. Methanol extract exhibited better activity than of all. Further, the wound healing property of stigmasterol isolated from methanol extract supports the present findings totally.

CONCLUSION

Excision Wound Model

The time for wound closure to methanol extract ointment (5% w/w) and stigmasterol (0.2% w/w) is similar to that of nitrofurazone ointment (0.2% w/w) 16±2 days and 18±2 days to chloroform and hexane extract in a dose-dependent manner.

Incision wound model

Activity is in the order of stigmasterol, methanol, chloroform and hexane extracts (5% w/w) respectively.

Excision and Incision Wound Models

Test extracts exhibit potent anti-inflammatory and antioxidant activities due to the presence of flavonoids and polyphenols which could have contributed wound healing in part; and Activity against Candida albicans indicates healing capacity of superficial skin infection.

ACKNOWLEDGMENT

The authors thank Illayavallal Dr. K. Sridharan, Chairman, Arulmigu Kalasalingam College of Pharmacy for providing necessary laboratory facilities for carrying out the present research work.

CONFLICT OF INTEREST

 No conflict of interest associated with this work.

REFERENCES

  1. Rajore S, Batra A. Jatropha curcas L: a plant of immense potential Value.  J Econ Tax Bot. 2003; 27: 36-41.
  2. Kirtikar KR, Basu BD. Indian Medicinal Plants, Oriental Enterprises, Dehradun, India. 2001; 2nd edn, Vols. I-4.
  3. Hartwell JL, 1969. Plants used against cancer; a survey.  Lloydia 32: 153-205.
  4. Ochse JJ, 1931. Vegetables of the Dutch East Indies. Reprinted 1980. A. Asherand Co., BV Amsterdam.
  5. List PH, Horhammer  1969-1979. Hager’s handbuch der pharmazeutischen praxis. Vols 2-6. Springer-Verlag, Berlin.
  6. Duke JA, Wain  Medicinal plants of the world. Computer index with more than 85,000 entries.  Three Volumes, Longman Group, UK Limited, UK, 1981.
  7. Watt JM, Breyer-Brandwijk MG. The medicinal and poisonous plants of southern and eastern Africa. 2nd E. and S. Livingstone, Ltd., London, 1962.
  8. Perry LM. Medicinal plants of East and Southeast Asia. MIT Press, Cambridge, 1980.
  9. Morton JF, 1981. Atlas of medicinal plants. C.C. Thomas, Springfield, IL.
  10. Tewari JP, Shukla IK. Inhibition of infectivity of 2 strains of watermelon mosaic virus by latex of some angiosperms. Geobios. 1982; 9: 124-126.
  11. Ellis JL, Saroja J. Bombay Nat Hist Soc. 1962; 58: 834.
  12. Harborne JB. Phytochemical Methods, 2nd Edition, Chapman and Hall, London, 1998.
  13. Udupa SL, Udupa AL, and Kulkarni DR. Anti-inflammatory and wound healing properties of Aloe vera. Fitoterapia. 1994; 65: 141-145.
  14. Saha K, Mutherjea PK, Das J, Pal M, Saha BP. Wound healing activity of Leucas lavandulaefolia J Ethnopharmacol. 1997; 56: 139-144.
  15. Udupa SL, Udupa AL, Kulkarni DR. Studies on the anti-inflammatory and wound healing properties of Maringa oleifera and Aegle marmelos. Fitoterapia. 1994; 65: 119-123.
  16. Jaswanth A, Akilandeswari S, Loganathan V, Manimaran S, and Ruckmani K. Wound Healing activity of Aegle marmelos. Indian J Pharm Sci. 2001; 63: 41-44.
  17. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994; 130: 489-493.
  18. Diegelmann RF, and Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004; 9: 283–289.
  19. Shukla A, Rasik AM, Jain GK, Shankar R, Kulshrestha  DK, Dhawan BN. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol. 1999;65:1–11.
  20. Ingold WM. Wound therapy: growth factors as agents to promote healing. Trends Biotechnol. 1993; 11: 387–392.
  21. Nath LK, and Dutta SK. Wound healing responses of the protelytic enzyme curcain. Indian J Pharmacol. 1992; 24: 114-115.
  22. Esimone CO, Nworu CS, Jackson CL. Cutaneous wound healing activity of a herbal ointment containing the leaf extract of Jatropha curcas (Euphorbiaceae). Int J Appl Res Nat Prod. 2009; 1: 1-4.
  23. Scott AC. Laboratory control of antimicrobial therapy. In: Colle JG, Duguid JP, Fraser AG, and Marmion BP, (Eds.) Mackie and McCartney Practical Medical Microbiology, 13thed, Volume 2. Churchill Livingstone: Edinburgh. Schweigerer, L. 1988. Basic fibroblast growth factor as wound healing harmone. Trends Pharmacol. 1989; 9: 427–428.
  24. Moulin V, Auger FA, Garel D, Germain, L. Role of wound healing myofibroblasts on re-epithelization of human skin. Burns. 2000; 26: 3-12.
  25. Udupa AL, Aithal  KS, Sharma SP, Vasanth Kumar Kulkarni DR, Rajgopal PK, Srinivasan KK. Anti-inflammatory and wound healing activity of the crude alcoholic extract and flvanoids from Vitexin lucoxylon. Fitoterapi.2005; 11: 263-265.
  26. Shetty S, Udupa S, Udupa L, and Somayaji N. Wound healing activity of Ocimum sanctum Linn with supportive role of antioxidant enzymes. Indian J Physiol. Pharmacol. 2006; 50: 163-168.
  27. Oboh FOJ, Masodje HI. Nutritional and Antimicrobial Properties of Vernonia amygdalina Int J Biomed. Health Sci. 2009; 5: 51-56.
  28. Mertz PM, Ovington LG, 1993. Wound healing Microbiology. Dermatol. Clin. 11: 739-747.
  29. Bikowski J. Secondarily infected wounds and dermatoses: a diagnosis and treatment guide. J Emerg Surg. 1999; 17: 197–206.
  30. Robson MC. Wound infection. A failure of wound healing caused by and imbalance of bacteria. Surg. Clin North Am. 1997; 77: 637-650.
  31. Essawi T, Srour M. Screening of some Palestinian medicinal plants for antibacterial activity. J Ethnopharmacol. 2000; 70: 343–349.
  32. Lupia E, Montrucchio G, Battglia E, Modena V, Camussi G. Role of tumor necrosis factor alpha and platelet activating factor in neo angiogenesis induced by synovial fluids of patients with the rheumatoid arthrits. Eur J Immunol. 1996; 6: 1690–1694.
  33. Moon EJ, Lee YM, Lee OH, Lee MJ, Lee SK, Chung MH, Park YI, Sung CK, Choi JS, Kim, KW. A novel angiogenic factor derived from Aloe vera gel: β–sitosterol, a plant sterol. Angiogenesis. 1999; 3: 117–123.
  34. Maheswari RK, Singh AK, Gaddipati J, and Srimal RC. Multiple biological activities of curcumin: A short review. Life Sci. 2006; 78: 2081–2087.
  35. Houghton PJ, Hylands PJ, Mensah AY, Hensel A, and Deters AM, 2005. In vitro tests and ethnopharmacological investigations: Wound healing as an example. J Ethnopharmacol. 2005; 100: 100-107.
  36. Bergstrom N, Allman RM, Alvarez OM, Bennett MA, Carlson CE, et al. Treatment of pressure ulcers. Clinical Practice Guideline No. 15, AHCPR Publication No.95-0652. Department of Health and Human Services, Public Health Services Agency for Health care Policy and Research, Rockville, M.D. U.S, 1994..
  37. Houghton PJ, Mensah AY. Buddleja and wound healing. SOFW-J. 1997; 123: 40–43.
  38. Singh M, Govindarajan R, Nath V, Rawat AKS, Mehrotra S. Antimicrobial, wound healing and antioxidant activity of Plagiochasma appendiculatum Lehm. et Lind. J. Ethnopharmacol. 2006; 107: 67-72.

 

Table 1:  Effect of various solvent extract of leaves and stigmasterol ointment on   excision wounds

Treatment

 

 

Dosage

 

 

Wound area (mm2) (% of wound contraction)

Post wounding days

0 day

4th day

8th day

12th day

16th day

18th day

Control

2%

w/w

521±20.00

(0.00)

458±13.50

(11.10)

368±14.10

(28.10)

278±13.30

(44.10)

207±10.80

(59.60)

179±13.80

(63.70)

Nitrofurazone   ointment            

0.2%

w/w

512±38.80

(0.00)

333±18.40

(34.50)

102±9.70*

(79.70)

30±2.00*

(94.00)

0.00*

(100.00)

0.00*

(100.00)

Hexane

extract

 

3% w/w

531±24.20 (0.00)

463±18.70

(12.80)

288±17.60

(45.76)

105±12.80

(80.18)

31±6.70

(94.16)

10±0.40

(98.11)

4% w/w

528±23.40

(0.00)

461±20.60

(12.68)

282±15.20

(46.59)

100±10.60

(62.10)

29±4.60

(94.50)

9±0.30

(98.29)

5% w/w

523±22.30

(0.00)

457±18.20

(12.60)

279±13.90

(46.65)

99±8.40

(80.90)

26±2.50

(95.02)

7±0.20

(98.66)

Chloroform

Extract

3% w/w

532±23.20

(0.00)

455±18.60

(14.47)

276±13.60

(48.12)

100±8.20

(81.20)

25±2.20

(94.17)

9±0.70

(98.30)

4% w/w

529±22.60

(0.00)

453±18.20

(14.36)

273±13.30

(48.39)

99±7.60

(81.28)

28±2.40

(94.70)

8±0.4

(98.48)

5% w/w

524±21.80(0.00)

449±12.80

(14.31)

269±12.80

(48.66)

96±7.40

(81.56)

31±2.60

(95.22)

6±0.20

(98.85)

Methanol

Extract

3% w/w

521±38.40

(0.00)

323±16.20

(38.00)

197±14.20

(62.18)

82±8.20

(84.26)

12±10.3

(97.69)

0.00

(100.00)

4% w/w

518±37.20

(0.00)

320±14.40

(38.22)

194±13.30

(62.54)

79±8.20

(84.74)

10±8.4

(98.06)

0.00

(100.00)

5% w/w

515±36.70

(0.00)

316±12.40

(38.64)

191±11.20

(62.91)

77±5.90

(83.88)

9±6.20

(98.07)

0.0*

(100.00)

Stigmasterol

0.2%

w/w

513±35.70

(0.00)

309±13.40

(37.80)

178±10.50

(57.80)

69±5.20*

(85.30)

8±5.60*

(99.00)

0.00*

(100.00)

Values are mean ± S.E.M. of six animals of each group *P<0.001 Vs respective control by student “t” test;

figures in parentheses represent percentage of wound contraction

Figure 1: Effect of various solvent extracts of leaves and stigmasterol ointment on excision wounds

  

Table 2: Effect of various solvent extracts of leaves and stigmasterol ointment on incision wounds in J. tanjorensis              

Treatment

 

Dosage

 

Tensile strength in (g)

Control

2% w/w

432.00±13.30

Nitrofurazone

0.2% w/w

597.00±14.80*

Hexane extract

3% w/w

519.00±9.60

4% w/w

521.00±9.80

5% w/w

526.00±10.00*

Chloroform extract

3% w/w

528.00±9.50

4% w/w

532.00±9.70

5% w/w

535.00±10.10

Methanol extract 

3% w/w

578.00±10.20*

4% w/w

581.00±10.40*

5% w/w

584.00±10.90*

Stigmasterol

0.2% w/w

591.00± 14.60*

Values are S.E.M. of six animals of each group; P<0.001 Vs Control by Student “t” test

 

   

Figure 2: Effect of various solvent extracts of leaves and stigmasterol ointment on incision wounds